Skip to main content
Top
Published in: Annals of Hematology 12/2009

01-12-2009 | Original Article

Clinical features and molecular analysis in Thai patients with HbH disease

Authors: Vichai Laosombat, Vip Viprakasit, Thirachit Chotsampancharoen, Malai Wongchanchailert, Sudarat Khodchawan, Worawut Chinchang, Benjamas Sattayasevana

Published in: Annals of Hematology | Issue 12/2009

Login to get access

Abstract

We studied the α-globin gene abnormalities, the clinical features, hematologic values, growth assessment, transfusion therapy, and serum ferritin levels of patients with hemoglobin H (HbH) disease in southern Thailand. HbH disease in 83 of the 147 patients was the deletional type of HbH. The remaining 64 patients was the nondeletional type of HbH disease. All 83 patients with the deletional type were double heterozygotes of α0-thalassemia and α+-thalassemia. The Southeast Asian type of α0-thalassemia accounted for 98% of the Thai patients with HbH disease and the Thai type of α0-thalassemia made up the rest. A 3.7-kb deletion accounted for 91% of α+-thalassemia, and a 4.2-kb deletion made up the rest of the deletional type. In patients with nondeletional type of HbH disease, the Constant Spring variant was the majority of the disease. Newborns with a nondeletional genotype had higher mean corpuscular volume, had higher mean corpuscular hemoglobin, had higher red blood cell distribution width, had lower mean corpuscular hemoglobin concentration, and had higher proportions of Hb Bart's than those with a deletional genotype. Twenty-one percent of children with HbH disease had growth deficiency. A genotype–phenotype correlation was found; patients with the nondeletional type of HbH disease had more symptoms at a younger age, more severe hemolytic anemia, more growth deficiency, more dysmorphic facial features, larger spleens, larger livers, and higher serum ferritin levels and required more transfusions than patients with deletional HbH disease.
Literature
1.
go back to reference Weatherall DJ, Clegg JB (2001) The thalassaemia syndromes, 4th edn. Blackwell Science, Oxford Weatherall DJ, Clegg JB (2001) The thalassaemia syndromes, 4th edn. Blackwell Science, Oxford
2.
go back to reference Na-Nakorn S, Wasi P (1970) Alpha-thalassemia in Northern Thailand. Am J Hum Genet 22(6):645–651PubMed Na-Nakorn S, Wasi P (1970) Alpha-thalassemia in Northern Thailand. Am J Hum Genet 22(6):645–651PubMed
3.
go back to reference Laosombat V, Panich V, Surapruk P, Pornpatkul M (1979) Alpha thalassemia in southern Thailand. In: Third Asian Congress of Pediatrics, Bangkok, Thailand, p 71 Laosombat V, Panich V, Surapruk P, Pornpatkul M (1979) Alpha thalassemia in southern Thailand. In: Third Asian Congress of Pediatrics, Bangkok, Thailand, p 71
4.
go back to reference Pansateinkul B, A Group of Thai Hematologists (1990) Current situation and strategic plan for prevention and control of blood diseases in Thailand 1989–1990, 1st edn. Num-Aksorn-Karnprim, Bangkok Pansateinkul B, A Group of Thai Hematologists (1990) Current situation and strategic plan for prevention and control of blood diseases in Thailand 1989–1990, 1st edn. Num-Aksorn-Karnprim, Bangkok
5.
go back to reference Higgs DR, Bowden DK (2001) Clinical and laboratory features of the α-thalassemia syndromes, 1st edn. Cambridge University Press, Cambridge Higgs DR, Bowden DK (2001) Clinical and laboratory features of the α-thalassemia syndromes, 1st edn. Cambridge University Press, Cambridge
6.
go back to reference Wickramasinghe SN, Fucharoen S, Wasi P (1986) Studies of erythropoietic cells in heterozygotes and homozygotes for haemoglobin Constant Spring and in heterozygotes for both haemoglobin Constant Spring and alpha-thalassaemia 1 trait: extent of globin chain precipitation and cell cycle distribution. Clin Lab Haematol 8(3):187–198PubMed Wickramasinghe SN, Fucharoen S, Wasi P (1986) Studies of erythropoietic cells in heterozygotes and homozygotes for haemoglobin Constant Spring and in heterozygotes for both haemoglobin Constant Spring and alpha-thalassaemia 1 trait: extent of globin chain precipitation and cell cycle distribution. Clin Lab Haematol 8(3):187–198PubMed
7.
go back to reference Yuan J, Bunyaratvej A, Fucharoen S, Fung C, Shinar E, Schrier SL (1995) The instability of the membrane skeleton in thalassemic red blood cells. Blood 86(10):3945–3950PubMed Yuan J, Bunyaratvej A, Fucharoen S, Fung C, Shinar E, Schrier SL (1995) The instability of the membrane skeleton in thalassemic red blood cells. Blood 86(10):3945–3950PubMed
9.
go back to reference Higgs DR (2001) Molecular mechanisms of α-thalassemia, 1st edn. Cambridge University Press, Cambridge Higgs DR (2001) Molecular mechanisms of α-thalassemia, 1st edn. Cambridge University Press, Cambridge
15.
go back to reference Working Group WHO (1986) Use and interpretation of anthropometric indicators of nutritional status. Bull World Health Organ 643:929–941 Working Group WHO (1986) Use and interpretation of anthropometric indicators of nutritional status. Bull World Health Organ 643:929–941
16.
go back to reference Papassotiriou I, Traeger-Synodinos J, Vlachou C et al (1999) Rapid and accurate quantitation of Hb Bart's and Hb H using weak cation exchange high performance liquid chromatography: correlation with the alpha-thalassemia genotype. Hemoglobin 23(3):203–211. doi:10.3109/03630269909005700 CrossRefPubMed Papassotiriou I, Traeger-Synodinos J, Vlachou C et al (1999) Rapid and accurate quantitation of Hb Bart's and Hb H using weak cation exchange high performance liquid chromatography: correlation with the alpha-thalassemia genotype. Hemoglobin 23(3):203–211. doi:10.​3109/​0363026990900570​0 CrossRefPubMed
17.
go back to reference Chong SS, Boehm CD, Higgs DR, Cutting GR (2000) Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood 95(1):360–362PubMed Chong SS, Boehm CD, Higgs DR, Cutting GR (2000) Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood 95(1):360–362PubMed
18.
go back to reference Viprakasit V, Tanphaichitr VS, Pung-Amritt P et al (2002) Clinical phenotypes and molecular characterization of Hb H-Pakse disease. Haematologica 87(2):117–125PubMed Viprakasit V, Tanphaichitr VS, Pung-Amritt P et al (2002) Clinical phenotypes and molecular characterization of Hb H-Pakse disease. Haematologica 87(2):117–125PubMed
19.
go back to reference Laosombat V, Wiriyasateinkul A, Chrangtrakul Y, Fucharoen S (2003) Rapid detection of an a thalassemia variant (Hb Quong Sze). Haematologica 88(7):ELT27PubMed Laosombat V, Wiriyasateinkul A, Chrangtrakul Y, Fucharoen S (2003) Rapid detection of an a thalassemia variant (Hb Quong Sze). Haematologica 88(7):ELT27PubMed
20.
go back to reference Laosombat V, Fucharoen S, Wiriyasateinkul A (2001) Interaction of the alpha2 polyadenylation signal mutation (AATAAA-->AATA--) and alpha0-thalassemia (--SEA), resulting in Hb H disease in a Thai patient. Hemoglobin 25(4):383–389. doi:10.1081/HEM-100107875 CrossRefPubMed Laosombat V, Fucharoen S, Wiriyasateinkul A (2001) Interaction of the alpha2 polyadenylation signal mutation (AATAAA-->AATA--) and alpha0-thalassemia (--SEA), resulting in Hb H disease in a Thai patient. Hemoglobin 25(4):383–389. doi:10.​1081/​HEM-100107875 CrossRefPubMed
22.
27.
go back to reference Sanchaisuriya K, Fucharoen G, Fucharoen S (2002) Hb Pakse [(alpha2) codon 142 (TAA-->TAT or Term-->Tyr) J in Thai patients with EAbart's disease and Hb H disease. Hemoglobin 26(3):227–235. doi:10.1081/HEM-120015026 CrossRefPubMed Sanchaisuriya K, Fucharoen G, Fucharoen S (2002) Hb Pakse [(alpha2) codon 142 (TAA-->TAT or Term-->Tyr) J in Thai patients with EAbart's disease and Hb H disease. Hemoglobin 26(3):227–235. doi:10.​1081/​HEM-120015026 CrossRefPubMed
30.
go back to reference Wasi P, Sookanek M, Pootrakul S, Na-Nakorn S, Suingdumrong A (1967) Haemoglobin E and alpha-Thalassaemia. BMJ 4(5570):29–32CrossRefPubMed Wasi P, Sookanek M, Pootrakul S, Na-Nakorn S, Suingdumrong A (1967) Haemoglobin E and alpha-Thalassaemia. BMJ 4(5570):29–32CrossRefPubMed
32.
go back to reference Liebhaber SA, Cash FE, Ballas SK (1986) Human alpha-globin gene expression. The dominant role of the alpha 2-locus in mRNA and protein synthesis. J Biol Chem 261(32):15327–15333PubMed Liebhaber SA, Cash FE, Ballas SK (1986) Human alpha-globin gene expression. The dominant role of the alpha 2-locus in mRNA and protein synthesis. J Biol Chem 261(32):15327–15333PubMed
35.
36.
go back to reference Chandrcharoensin-Wilde C, Chairoongruang S, Jitnuson P, Fucharoen S, Vathanopas V (1988) Gallstones in thalassemia. Birth Defects Orig Artic Ser 23(5B):263–267PubMed Chandrcharoensin-Wilde C, Chairoongruang S, Jitnuson P, Fucharoen S, Vathanopas V (1988) Gallstones in thalassemia. Birth Defects Orig Artic Ser 23(5B):263–267PubMed
37.
go back to reference Lin CK, Gau JP, Hsu HC, Jiang ML (1990) Efficacy of a modified improved technique for detecting red cell haemoglobin H inclusions. Clin Lab Haematol 12(4):409–415PubMedCrossRef Lin CK, Gau JP, Hsu HC, Jiang ML (1990) Efficacy of a modified improved technique for detecting red cell haemoglobin H inclusions. Clin Lab Haematol 12(4):409–415PubMedCrossRef
40.
go back to reference Fucharoen S, Winichagoon P, Pootrakul P, Piankijagum A, Wasi P (1987) Differences between two types of Hb H disease, alpha-thalassemia 1/alpha-thalassemia 2 and alpha-thalassemia 1/Hb Constant Spring. Birth Defects Orig Artic Ser 23(5A):309–315PubMed Fucharoen S, Winichagoon P, Pootrakul P, Piankijagum A, Wasi P (1987) Differences between two types of Hb H disease, alpha-thalassemia 1/alpha-thalassemia 2 and alpha-thalassemia 1/Hb Constant Spring. Birth Defects Orig Artic Ser 23(5A):309–315PubMed
Metadata
Title
Clinical features and molecular analysis in Thai patients with HbH disease
Authors
Vichai Laosombat
Vip Viprakasit
Thirachit Chotsampancharoen
Malai Wongchanchailert
Sudarat Khodchawan
Worawut Chinchang
Benjamas Sattayasevana
Publication date
01-12-2009
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 12/2009
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-009-0743-5

Other articles of this Issue 12/2009

Annals of Hematology 12/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.